Cargando…

Host Cell Restriction Factors that Limit Influenza A Infection

Viral infection of different cell types induces a unique spectrum of host defence genes, including interferon-stimulated genes (ISGs) and genes encoding other proteins with antiviral potential. Although hundreds of ISGs have been described, the vast majority have not been functionally characterised....

Descripción completa

Detalles Bibliográficos
Autores principales: Villalón-Letelier, Fernando, Brooks, Andrew G., Saunders, Philippa M., Londrigan, Sarah L., Reading, Patrick C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744151/
https://www.ncbi.nlm.nih.gov/pubmed/29215570
http://dx.doi.org/10.3390/v9120376
_version_ 1783288698267238400
author Villalón-Letelier, Fernando
Brooks, Andrew G.
Saunders, Philippa M.
Londrigan, Sarah L.
Reading, Patrick C.
author_facet Villalón-Letelier, Fernando
Brooks, Andrew G.
Saunders, Philippa M.
Londrigan, Sarah L.
Reading, Patrick C.
author_sort Villalón-Letelier, Fernando
collection PubMed
description Viral infection of different cell types induces a unique spectrum of host defence genes, including interferon-stimulated genes (ISGs) and genes encoding other proteins with antiviral potential. Although hundreds of ISGs have been described, the vast majority have not been functionally characterised. Cellular proteins with putative antiviral activity (hereafter referred to as “restriction factors”) can target various steps in the virus life-cycle. In the context of influenza virus infection, restriction factors have been described that target virus entry, genomic replication, translation and virus release. Genome wide analyses, in combination with ectopic overexpression and/or gene silencing studies, have accelerated the identification of restriction factors that are active against influenza and other viruses, as well as providing important insights regarding mechanisms of antiviral activity. Herein, we review current knowledge regarding restriction factors that mediate anti-influenza virus activity and consider the viral countermeasures that are known to limit their impact. Moreover, we consider the strengths and limitations of experimental approaches to study restriction factors, discrepancies between in vitro and in vivo studies, and the potential to exploit restriction factors to limit disease caused by influenza and other respiratory viruses.
format Online
Article
Text
id pubmed-5744151
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57441512017-12-31 Host Cell Restriction Factors that Limit Influenza A Infection Villalón-Letelier, Fernando Brooks, Andrew G. Saunders, Philippa M. Londrigan, Sarah L. Reading, Patrick C. Viruses Review Viral infection of different cell types induces a unique spectrum of host defence genes, including interferon-stimulated genes (ISGs) and genes encoding other proteins with antiviral potential. Although hundreds of ISGs have been described, the vast majority have not been functionally characterised. Cellular proteins with putative antiviral activity (hereafter referred to as “restriction factors”) can target various steps in the virus life-cycle. In the context of influenza virus infection, restriction factors have been described that target virus entry, genomic replication, translation and virus release. Genome wide analyses, in combination with ectopic overexpression and/or gene silencing studies, have accelerated the identification of restriction factors that are active against influenza and other viruses, as well as providing important insights regarding mechanisms of antiviral activity. Herein, we review current knowledge regarding restriction factors that mediate anti-influenza virus activity and consider the viral countermeasures that are known to limit their impact. Moreover, we consider the strengths and limitations of experimental approaches to study restriction factors, discrepancies between in vitro and in vivo studies, and the potential to exploit restriction factors to limit disease caused by influenza and other respiratory viruses. MDPI 2017-12-07 /pmc/articles/PMC5744151/ /pubmed/29215570 http://dx.doi.org/10.3390/v9120376 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Villalón-Letelier, Fernando
Brooks, Andrew G.
Saunders, Philippa M.
Londrigan, Sarah L.
Reading, Patrick C.
Host Cell Restriction Factors that Limit Influenza A Infection
title Host Cell Restriction Factors that Limit Influenza A Infection
title_full Host Cell Restriction Factors that Limit Influenza A Infection
title_fullStr Host Cell Restriction Factors that Limit Influenza A Infection
title_full_unstemmed Host Cell Restriction Factors that Limit Influenza A Infection
title_short Host Cell Restriction Factors that Limit Influenza A Infection
title_sort host cell restriction factors that limit influenza a infection
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744151/
https://www.ncbi.nlm.nih.gov/pubmed/29215570
http://dx.doi.org/10.3390/v9120376
work_keys_str_mv AT villalonletelierfernando hostcellrestrictionfactorsthatlimitinfluenzaainfection
AT brooksandrewg hostcellrestrictionfactorsthatlimitinfluenzaainfection
AT saundersphilippam hostcellrestrictionfactorsthatlimitinfluenzaainfection
AT londrigansarahl hostcellrestrictionfactorsthatlimitinfluenzaainfection
AT readingpatrickc hostcellrestrictionfactorsthatlimitinfluenzaainfection